Biotechnology & Pharmaceutical Services Outsourcing Market by Services, End-User - Global Forecast 2025-2030- Product Image

Sale

Biotechnology & Pharmaceutical Services Outsourcing Market by Services, End-User - Global Forecast 2025-2030

Report
180 Pages
October 2024
Region: Global
360iResearch™
ID: 6010907

UP TO €684EUR$697USD£572GBP OFF until Dec 31^st 2024

The Biotechnology & Pharmaceutical Services Outsourcing Market grew from USD 150.82 billion in 2023 to USD 167.95 billion in 2024. It is expected to continue growing at a CAGR of 11.84%, reaching USD 330.17 billion by 2030.

The Biotechnology & Pharmaceutical Services Outsourcing market involves the delegation of operations, such as drug discovery, development, manufacturing, and related functions, to specialized third-party service providers. This outsourcing is necessary for companies to streamline operations, reduce costs, and enhance efficiency while focusing on core competencies. Application spans across various stages of drug development, from clinical research to regulatory submissions, offering services to both emerging biotech firms and large pharmaceutical companies. The end-use scope includes Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), and more, catering to diverse client needs. Key factors influencing growth include the increasing complexity of drug development processes, rising R&D costs, and technological advancements such as artificial intelligence and big data analytics in research and development. Opportunities exist in personalized medicine, with an emphasis on niche therapeutics and rare disease drug development. Companies can capitalize on the growing demand for specialized and customized services by investing in precision medicine and biologics production capabilities. Despite its potential, the market faces challenges, including the high risk of regulatory non-compliance, intellectual property concerns, and the need to maintain high-quality standards across geographically diverse operations. Limitations also arise from fluctuating service pricing and competition from alternative service regions, imposing pressure on profitability margins. Best areas for innovation involve developing adaptive technologies, specifically in biologics manufacturing and AI-driven data analytics, to offer scalable and efficient solutions. Research into AI integration for predictive modeling in clinical trials can provide a competitive edge. The market remains dynamic, shaped by regulatory frameworks, technological trends, and shifting client demands. Businesses that align with emerging trends and manage risks while capitalizing on digital transformation and strategic partnerships will likely see sustained growth in this complex yet rewarding industry.

Understanding Market Dynamics in the Biotechnology & Pharmaceutical Services Outsourcing Market

The Biotechnology & Pharmaceutical Services Outsourcing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing R&D expenditure of pharmaceutical and biopharmaceutical industry
- Rising demand for outsourcing services in drug development
- Growing regulatory support activities including labeling and documentation
Market Restraints
- Issues associated with monitoring and lack of standardization
Market Opportunities
- Rising outsourcing of generics and biosimilar manufacturing
- Outsourcing of clinical trial activity
Market Challenges
- Issues associated with data security and increasing lead time and logistics costs

Exploring Porter’s Five Forces for the Biotechnology & Pharmaceutical Services Outsourcing Market

Porter’s Five Forces framework further strengthens the insights of the Biotechnology & Pharmaceutical Services Outsourcing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biotechnology & Pharmaceutical Services Outsourcing Market

External macro-environmental factors deeply influence the performance of the Biotechnology & Pharmaceutical Services Outsourcing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biotechnology & Pharmaceutical Services Outsourcing Market

The Biotechnology & Pharmaceutical Services Outsourcing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biotechnology & Pharmaceutical Services Outsourcing Market

The Biotechnology & Pharmaceutical Services Outsourcing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biotechnology & Pharmaceutical Services Outsourcing Market

The Biotechnology & Pharmaceutical Services Outsourcing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology & Pharmaceutical Services Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, CEVA Logistics AG, Charles River Laboratories, Inc., Concept Heidelberg GmbH, Curia Global, Inc., Dalton Pharma Services by Seikagaku Corporation, DHL International GmbH, Eurofins Scientific (Ireland) Limited, Evotec SE, GenScript Biotech Corporation, Hitachi Ltd., Icon PLC, IQVIA HOLDINGS, INC., Laboratory Corporation of America Holdings, Lachman Consultant Services, Inc., McKesson Corporation by Aurelius Group, Parexel International Corporation, The Quantic Group, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Biotechnology & Pharmaceutical Services Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
- Auditing & Assessment
- Consulting
  - Quality Management Systems Consulting
  - Regulatory Compliance
  - Remediation
- Product Design & Development
- Product Maintenance
- Product Testing & Validation
- Regulatory Affairs
  - Clinical Trial Applications & Product Registration
  - Legal Representation
  - Regulatory Writing & Publishing
- Training & Education
End-User
- Biotech Companies
- Pharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D expenditure of pharmaceutical and biopharmaceutical industry
5.1.1.2. Rising demand for outsourcing services in drug development
5.1.1.3. Growing regulatory support activities including labeling and documentation
5.1.2. Restraints
5.1.2.1. Issues associated with monitoring and lack of standardization
5.1.3. Opportunities
5.1.3.1. Rising outsourcing of generics and biosimilar manufacturing
5.1.3.2. Outsourcing of clinical trial activity
5.1.4. Challenges
5.1.4.1. Issues associated with data security and increasing lead time and logistics costs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Biotechnology & Pharmaceutical Services Outsourcing Market, by Services

6.1. Introduction
6.2. Auditing & Assessment
6.3. Consulting
6.3.1. Quality Management Systems Consulting
6.3.2. Regulatory Compliance
6.3.3. Remediation
6.4. Product Design & Development
6.5. Product Maintenance
6.6. Product Testing & Validation
6.7. Regulatory Affairs
6.7.1. Clinical Trial Applications & Product Registration
6.7.2. Legal Representation
6.7.3. Regulatory Writing & Publishing
6.8. Training & Education

7. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-User

7.1. Introduction
7.2. Biotech Companies
7.3. Pharmaceutical Companies

8. Americas Biotechnology & Pharmaceutical Services Outsourcing Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
TABLE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY QUALITY MANAGEMENT SYSTEMS CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REMEDIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS & PRODUCT REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 40. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 41. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 42. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 44. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 63. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 64. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 66. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 67. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 68. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 75. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 76. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 99. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 100. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 112. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 113. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 115. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 116. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 117. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 119. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 120. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 121. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 124. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 136. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 137. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 148. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 149. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 151. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 152. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 153. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 156. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 157. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 171. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 172. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 183. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 184. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 185. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biotechnology & Pharmaceutical Services Outsourcing market, which are profiled in this report, include:

AmerisourceBergen Corporation
CEVA Logistics AG
Charles River Laboratories, Inc.
Concept Heidelberg GmbH
Curia Global, Inc.
Dalton Pharma Services by Seikagaku Corporation
DHL International GmbH
Eurofins Scientific (Ireland) Limited
Evotec SE
GenScript Biotech Corporation
Hitachi Ltd.
Icon PLC
IQVIA HOLDINGS, INC.
Laboratory Corporation of America Holdings
Lachman Consultant Services, Inc.
McKesson Corporation by Aurelius Group
Parexel International Corporation
The Quantic Group
WuXi AppTec Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 167.95 Billion
Forecasted Market Value ( USD ) by 2030	$ 330.17 Billion
Compound Annual Growth Rate	11.8%
Regions Covered	Global
No. of Companies Mentioned	19

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3480EUR$3,545USD£2,908GBP €3866EUR$3,939USD£3,231GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6156EUR$6,272USD£5,145GBP €6840EUR$6,969USD£5,716GBP

Understanding Market Dynamics in the Biotechnology & Pharmaceutical Services Outsourcing Market

Exploring Porter’s Five Forces for the Biotechnology & Pharmaceutical Services Outsourcing Market

Applying PESTLE Analysis to the Biotechnology & Pharmaceutical Services Outsourcing Market

Analyzing Market Share in the Biotechnology & Pharmaceutical Services Outsourcing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biotechnology & Pharmaceutical Services Outsourcing Market

Strategic Recommendations for Success in the Biotechnology & Pharmaceutical Services Outsourcing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report by Service (Consulting, Auditing & Assessment), End-use (Pharmaceutical Companies, Biotech Companies), Region, and Segment Forecasts, 2024-2030

Pharmaceutical Services Outsourcing Market by Service, End-Use - Global Forecast 2025-2030

Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report

North America Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End Use, By Country, And Segment Forecasts, 2024 - 2030

Biologics Outsourcing Market by Product Type, Application, Source, Service Type, End User, Therapeutic Area - Global Forecast 2025-2030